Effects of omega-3 on metabolic markers in postmenopausal women with metabolic syndrome

References

• Schneider JG, Tompkins C, Blumenthal RS, Mora S. The metabolic syndrome in women. Cardiol Rev 2006;14:286–91
   PubMedGoogle Scholar
• Ford ES, Giles WH, Mokad A. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004;27: 2444–9
   PubMed Web of Science ®Google Scholar
• Nahas EAP, Padoani NP, Nahas-Neto J, Orsatti FL, Tardivo AP, Dias R. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climacteric 2009;12:431–8
   PubMed Web of Science ®Google Scholar
• Jou-Wei L, Caffrey JL, Chang MH, Lin YS. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality-cohort analysis from the third national health and nutrition examination survey. J Clin Endocrinol Metab 2010;95:4258–67
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448–54
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. The importance of the Omega-6/Omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 2008;233:674–88.
   PubMed Web of Science ®Google Scholar
• Vannice GK. N-3s from fish and the risk of metabolic syndrome. J Am Diet Assoc 2010;110:1014–17
   PubMed Web of Science ®Google Scholar
• Roth EM, Harris WS. Fish oil for primary and secondary prevention of coronary heart disease. Curr Atheroscler Res 2010; 12:66–72
   PubMed Web of Science ®Google Scholar
• Calder PC. N-3 polyunsaturarted fatty acids, inflammation, and inflammatory diseases. Am J Nutr 2006;83:S1505–9
   PubMed Web of Science ®Google Scholar
• Hu FB, Bronner I, Willett WC, et al. Fish and omega-3 fatty acids intake and risk of coronary heart disease in women. JAMA 2002;287:1815–21
   PubMed Web of Science ®Google Scholar
• He K, Liu K, Daviglus ML, et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation from the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Cardiol 2009;103:1238–43
   PubMed Web of Science ®Google Scholar
• Mori TA. Omega-3 fatty acids and blood pressure. Cell Mol Biol 2010;56:83–92
   PubMed Web of Science ®Google Scholar
• Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010;375:540–50
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Harris WS, Appel LJ, for the Nutrition Committee. AHA scientific statement: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747–57
   PubMed Web of Science ®Google Scholar
• Musa-Veloso K, Binns MA, Kocenas AC, et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev 2010;68:155–67
   PubMed Web of Science ®Google Scholar
• Pirillo A, Catapano AL. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia. Int J Cardiol 2013; 170:S16–20
   PubMed Web of Science ®Google Scholar
• Browning LM, Krebs JD, Moore CS, Mishra GD, O’Connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007;9:70–80
   PubMed Web of Science ®Google Scholar
• Baik I, Abbott RD, Curb JD, Shin C. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 2010;110:1018–26
   PubMed Web of Science ®Google Scholar
• Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Prog Lipid Res 2011;50:372–87
   PubMed Web of Science ®Google Scholar
• Lopez-Huertas E. The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomized controlled trials. Br J Nutr 2012;107:S185–94
   PubMed Web of Science ®Google Scholar
• Abeywardena MY, Patten GS. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. Endocr Metab Immune Disord Drug Targets 2011;11:232–46
   PubMedGoogle Scholar
• Dewell A, Marvasti FF, Harris WS, Tsao P, Gardner CD. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr 2011;141:2166–71
   PubMed Web of Science ®Google Scholar
• Ciubotaru I, Lee YS, Wander RC. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003;14:513–21
   PubMed Web of Science ®Google Scholar
• Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;134: 1806–11
   PubMed Web of Science ®Google Scholar
• Expert Panel on the detection, evaluation, and treatment of high blood pressure in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Adult Treatment Panel III (ATP III). JAMA 2001;285:2444–9
   Google Scholar
• Thompson FE, Byers T. Dietary assessment resource manual. J Nutr 1994;124:S2245–317
   PubMed Web of Science ®Google Scholar
• Anção MS, Cuppari L, Draibe AS. Programa de Apoio à nutrição – NutWin, versão 1.5 [CD ROM]. São Paulo: Departamento de Informática em Saúde – SPDM – UNIFESP/EPM, 2002
   Google Scholar
• National Academy of Sciences. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty acids, Cholesterol, Protein, and Aminoacids (macronutrients). Washington: National Academy Press, 2005
   Google Scholar
• [[[List:1::OutlineNumbering::]]]Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810–17
   PubMed Web of Science ®Google Scholar
• Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixture population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006;72:219–20
   PubMed Web of Science ®Google Scholar
• Millen BE, Pencina MJ, Kimokoti RW, Meigs JB, Ordovas JM, D’Agostino RB. Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr 2006;84:434–41
   PubMed Web of Science ®Google Scholar
• Tardivo AP, Nahas-Neto J, Nahas EAP, Maesta N, Rodrigues MH, Orsatti FL. Associations between healthy eating patterns and indicators of metabolic risk in postmenopausal women. Nutr J 2010;9:64
   PubMed Web of Science ®Google Scholar
• Van Horn L, McCoin M, Kris-Etherton PM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 2008;108:287–331
   PubMed Web of Science ®Google Scholar
• Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009;139:S804–19
   PubMed Web of Science ®Google Scholar
• Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr 2008;87:198–90S
   Google Scholar
• Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: meta-regression analysis randomized trials. J Hypertens 2002;20:1493–9
   PubMed Web of Science ®Google Scholar
• Gulseth HL, Gjelstad IM, Tierney AC, et al. Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in LIPGENE dietary intervention study. Br J Nutr 2010;104:160–3
   PubMed Web of Science ®Google Scholar
• Benito P, Caballero J, Moreno J, et al. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 2006;25:581–7
   PubMed Web of Science ®Google Scholar
• Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol 2009;64:321–7
   PubMed Web of Science ®Google Scholar
• Griffin BA. Goldilocks and the three bonds: new evidence for the conditional benefits of dietary α-linolenic acid in treating cardiovascular risk in the metabolic syndrome. Br J Nutr 2012; 108:579–80
   PubMed Web of Science ®Google Scholar
• Brady LM, Williams CM, Lovegrove JA. Dietary PUFA and the metabolic syndrome in Indian Asians living in the UK. Proc Nutr Soc 2004;63:115–25
   PubMed Web of Science ®Google Scholar
• Satoh N, Shimatsu A, Kotani K, et al. Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care 2007;30:144–6
   PubMed Web of Science ®Google Scholar
• Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2008;CD003205
   PubMed Web of Science ®Google Scholar
• Kalupahana NS, Claycombe KJ, Moustaid-Moussa N. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr 2011;2:304–16
   PubMed Web of Science ®Google Scholar
• Flashs P, Rossmeisl M, Kopecky J. The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity. Physiol Res 2014;63:S93–118
   Google Scholar
• Buscemi S, Nicolucci A, Lucisano G, et al. Habitual fish intake and clinically silent carotid atherosclerosis. Nutr J 2014;13:2
   PubMed Web of Science ®Google Scholar
• Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000;71:171–5S
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Plastiras A, Siasos G, et al. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis 2014;232:10–16
   PubMed Web of Science ®Google Scholar
• Vega-López S, Kaul N, Devaraj S, Cai RY, German B, Jialal I. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 2004;53:236–40
   PubMed Web of Science ®Google Scholar
• Pot GK, Brouwer IA, Enneman A, Rijkers GT, Kampman E, Geelen A. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals. Eur J Clin Nutr 2009;63:1353–9
   PubMed Web of Science ®Google Scholar
• Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 2011;93:243–52
   PubMed Web of Science ®Google Scholar